Anthropic has launched Claude for Healthcare, a suite of AI tools for health systems, payers, and patients, in the latest ...

European Commission approves Sanofi’s Teizeild to treat patients with stage 2 type 1 diabetes: Paris Tuesday, January 13, 2026, 11:00 Hrs [IST] The European Commission has appro ...

Anthropic has launched Claude for Healthcare, a HIPAA-ready AI platform for hospitals and pharmaceutical companies, days ...

The company in 2026 is seeking approval from global regulators for Casgevy and two cystic fibrosis drugs in younger patients.

LimX COSA powers the Oli humanoid with a three-layer stack that blends cognition and whole-body control, enabling agents to handle complex tasks safely ...

Ethereum co-founder Vitalik Buterin says the network should be able to function for decades without relying on constant ...

The FAA in October 2024 published a special federal aviation regulation (SFAR) with seismic implications for the aviation ...

Explore the groundbreaking role of the OTULIN enzyme in regulating the immune system and its link to neurodegenerative ...

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects total U.S. net product sales for the fourth quarter of 2025 to be ...

Explore why tau still lacks treatments despite its critical role in Alzheimer's disease and other tauopathies.

Skin with a "healthy glow" is officially the beauty industry's most-coveted aesthetic. Here is how two powerhouses achieved ...

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...